Atlas FDA

MERLIN PTCA CATHETER (OTW) AND NC MERLIN PTCA CATHETER (OTW)

FDA premarket approval P910031/S023 · decided 2006-02-16

Approval details

PMA number
P910031
Supplement
S023
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MERLIN PTCA CATHETER (OTW) AND NC MERLIN PTCA CATHETER (OTW)
Generic name
Catheters, transluminal coronary angioplasty, percutaneous
Applicant
Abbott Vascular Devices
Date received
2004-11-16
Decision date
2006-02-16
Days to decision
457 days
Decision code
APPR
Product code
LOX
Advisory committee
Cardiovascular
Expedited review
No
Location
Redwood, CA
Statement
APPROVAL FOR THE MERLIN PTCA CATHETER (OTW) AND NC MERLIN PTCA CATHETER (OTW). THE MERLIN PTCA CATHETER (OTW) IS INDICATED FOR USE IN BALLOON DILATATION OF THE STENOTIC PORTION OF A CORONARY ARTERY OR BYPASS GRAFT STENOSIS FOR THE PURPOSE OF IMPROVING MYOCARDIAL PERFUSION. THE NC MERLIN PTCA CATHETER (OTW) IS INDICATED FOR USE IN BALLOON DILATATION OF THE STENOTIC PORTION OF A CORONARY ARTERY OR BYPASS GRAFT STENOSIS FOR THE PURPOSE OF IMPROVING MYOCARDIAL PERFUSION, AND FOR THE POST-DELIVERY EX

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
THE EMBOSHIELD EMBOLIC PROTECTION SYSTEM (K052454)Abbott Vascular Devices2005-09-14
MODIFICATION TO: XCEED NITINOL SELF-EXPANDING TRANSHEPATIC BILIARY STENT SYSTEM (K050501)Abbott Vascular Devices2005-03-14